Information Provided By: 
Fly News Breaks for April 10, 2018
TNDM
Apr 10, 2018 | 10:24 EDT
Piper Jaffray analyst JP McKim noted that Tandem Diabetes announced preliminary Q1 revenue that beat his estimate of $24.8M and the consensus view near $25M. McKim, who thinks the company "clearly benefited" from the exit of Animas from the U.S. market, is incrementally more positive on Tandem but awaits more evidence of an accelerating growth trend before changing his Neutral rating on the stock.
News For TNDM From the Last 2 Days
There are no results for your query TNDM
